Colgate-Palmolive (NYSE:CL) Rating Lowered to Hold at StockNews.com

StockNews.com downgraded shares of Colgate-Palmolive (NYSE:CL) from a buy rating to a hold rating in a report released on Tuesday morning.

A number of other equities research analysts have also commented on CL. Raymond James reissued an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Finally, UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Stock Down 1.5 %

Shares of CL opened at $89.52 on Tuesday. The company has a market capitalization of $72.65 billion, a P/E ratio of 25.43, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The business’s 50 day simple moving average is $89.44 and its 200-day simple moving average is $93.82. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company earned $0.87 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.32%. Colgate-Palmolive’s dividend payout ratio is 56.82%.

Colgate-Palmolive declared that its Board of Directors has authorized a share repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

Hedge Funds Weigh In On Colgate-Palmolive

Institutional investors have recently modified their holdings of the business. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Vermillion Wealth Management Inc. bought a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $31,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.